HKG Equity Snapshot

6990 Weekly Equity Report

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Interactive chart JSON snapshot
Latest Close 415.2 HKD 12 Jun 2026
1W Return 5.5% latest completed week
4W Return -4.9% short-term follow-through
12W Return -0.6% quarterly tape
Trend Breadth 65.4% 34 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
Company Brief

What the company does

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People's Republic of China and internationally. The company's product pipeline includes Sac-TMT, a novel TROP2 ADC positioned as a monotherapy and part of combination therapies for treating various advanced solid tumors; Trastuzumab botidotin, a monotherapy to treat advanced HER2+ solid tumors; SKB315, a novel CLDN18.2 ADC targeting advanced solid tumors; SKB410/MK-3120, a novel Nectin-4 ADC targeting advanced solid tumors; and SKB571/MK-2750, a novel bsADC primarily …

Snapshot

What the weekly tape is saying

6990 closed the latest completed week at 415.2 HKD. The 4-week return is -4.9% and the 12-week return is -0.6%. Trend Signal is inactive, Market Dynamics is 0.41. Setup signature: Risk-first tape with a 34/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -5.7%
Volume 1.5x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 36 Persistence of active Trend Signal over the last year and current streak.
Momentum 38 Blend of 4-week and 12-week follow-through.
Dynamics 58 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 4 Relative leadership and short-term RS change.
Volume 62 Participation compared with the 13-week volume baseline.
Risk Control 8 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
440.3 HKD
Vs Trend Line
-5.7%
Fair Value
255.6 HKD
Vs Fair Value
62.4%
52W High
581.0 HKD
52W Low
314.2 HKD
Drawdown
-28.5%
Range Position
37.9%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 5.5%
4W -4.9%
12W -0.6%
26W -5.3%
52W 19.7%

Trend read

Active Streak
0 weeks
52W Active Weeks
34
52W Active Breadth
65.4%
Sector Scope
HK Healthcare
Sector Rank
27 of 257
Sector Percentile
89.8%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.41
4W MD Change
8.4%
Relative Strength
-1.33
4W RS Change
-524.2%
Expectation
Undecided
Probability
50.37%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
5.0M
13W Average
3.3M
52W Average
3.2M
Vs 13W
1.5x
Vs 52W
1.5x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
7.3%
52W Volatility
7.6%
Upside Weeks
22
Downside Weeks
30
Downside Breadth
57.7%
Avg Gain / Loss
7.9% / -4.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
HKG
Country
HK
Sector
Healthcare
Industry
Biotechnology
Currency
HKD
Market Cap
101.5B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.
  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 415.2 HKD 5.5% 440.3 HKD 255.6 HKD 0.41 -1.33 5.0M Off
5 Jun 2026 393.4 HKD -14.8% 442.0 HKD 254.6 HKD 0.51 -7.18 6.2M Off
29 May 2026 462.0 HKD -2.6% 442.5 HKD 253.6 HKD 0.54 8.24 4.9M On
22 May 2026 474.2 HKD 8.6% 442.0 HKD 252.2 HKD 0.45 9.84 5.0M On
15 May 2026 436.6 HKD -2.4% 440.8 HKD 250.8 HKD 0.38 0.31 3.0M On
8 May 2026 447.2 HKD -4.7% 441.6 HKD 249.5 HKD 0.61 1.43 1.7M On
1 May 2026 469.4 HKD -1.8% 442.9 HKD 248.2 HKD 0.76 9.38 1.3M On
24 Apr 2026 477.8 HKD -8.1% 446.0 HKD 246.6 HKD 0.91 10.85 2.8M Off
17 Apr 2026 520.0 HKD 5.5% 446.3 HKD 245.0 HKD 0.83 20.50 2.9M Off
10 Apr 2026 493.0 HKD -2.1% 445.9 HKD 243.1 HKD 0.45 16.30 1.9M Off
3 Apr 2026 503.5 HKD 10.0% 446.4 HKD 241.4 HKD 0.04 23.12 3.2M Off
27 Mar 2026 457.6 HKD 9.6% 447.1 HKD 239.5 HKD -0.41 13.51 2.8M Off
20 Mar 2026 417.6 HKD 5.8% 447.0 HKD 238.0 HKD -0.70 2.98 2.8M Off
13 Mar 2026 394.8 HKD 2.2% 448.6 HKD 236.7 HKD -0.87 -2.72 2.6M Off